SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Production and Quality Requirements of Human Platelet Lysate: A Position Statement from the Working Party on Cellular Therapies of the International Society of Blood Transfusion.

Schallmoser, K; Henschler, R; Gabriel, C; Koh, MBC; Burnouf, T (2020) Production and Quality Requirements of Human Platelet Lysate: A Position Statement from the Working Party on Cellular Therapies of the International Society of Blood Transfusion. Trends Biotechnol, 38 (1). pp. 13-23. ISSN 1879-3096 https://doi.org/10.1016/j.tibtech.2019.06.002
SGUL Authors: Koh, Mickey

[img]
Preview
PDF Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (2MB) | Preview

Abstract

Human platelet lysate (HPL), rich in growth factors, is an efficient alternative supplement to fetal bovine serum (FBS) for ex vivo propagation of stromal cell-based medicinal products. Since 2014, HPL has been a focus of the Working Party for Cellular Therapies of the International Society of Blood Transfusion (ISBT). Currently, as several Good Manufacturing Practice (GMP)-compliant manufacturing protocols exist, an international consensus defining the optimal modes of industrial production, product specification, pathogen safety, and release criteria of this ancillary material (AM) is needed. This opinion article by the ISBT Working Party summarizes the current knowledge on HPL production and proposes recommendations on manufacturing and quality management in line with current technological innovations and regulations of biological products and advanced therapy medicinal products.

Item Type: Article
Additional Information: © 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
Keywords: cell propagation, cell therapy, human platelet lysate, mesenchymal stromal cells, Biotechnology, 06 Biological Sciences, 09 Engineering, 10 Technology
SGUL Research Institute / Research Centre: Academic Structure > Institute of Medical & Biomedical Education (IMBE)
Academic Structure > Institute of Medical & Biomedical Education (IMBE) > Centre for Clinical Education (INMECE )
Journal or Publication Title: Trends Biotechnol
ISSN: 1879-3096
Language: eng
Dates:
DateEvent
January 2020Published
17 July 2019Published Online
12 June 2019Accepted
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
PubMed ID: 31326128
Web of Science ID: WOS:000503376700005
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/112057
Publisher's version: https://doi.org/10.1016/j.tibtech.2019.06.002

Actions (login required)

Edit Item Edit Item